|
May 1
|
SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2024 RESULTS
|
|
Apr 22
|
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
|
|
Apr 1
|
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
|
|
Mar 26
|
SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE DATE
|
|
Mar 25
|
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.
|
|
Mar 15
|
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million
|
|
Mar 5
|
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study
|
|
Mar 1
|
Summit Hotel Properties, Inc. (NYSE:INN) Q4 2023 Earnings Call Transcript
|
|
Mar 1
|
Q4 2023 Summit Hotel Properties Inc Earnings Call
|
|
Feb 29
|
Summit Hotel Properties (INN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Feb 28
|
SUMMIT HOTEL PROPERTIES REPORTS FOURTH QUARTER AND FULL YEAR 2023 RESULTS
|
|
Feb 26
|
Innovative Industrial Properties (IIPR) Q4 FFO and Revenues Surpass Estimates
|
|
Feb 26
|
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits
|
|
Feb 26
|
Gear Up for Summit Hotel Properties (INN) Q4 Earnings: Wall Street Estimates for Key Metrics
|
|
Feb 1
|
Zacks.com featured highlights include First Bank, CEMEX, Costamare, ASE Technology and Summit Hotel Properties
|
|
Jan 31
|
Pick These 5 Bargain Stocks With Enticing EV-to-EBITDA Ratios
|
|
Jan 30
|
Are Investors Undervaluing Brandywine Realty Trust (BDN) Right Now?
|
|
Jan 12
|
Wolfe Research Initiates Coverage On Four Hotel REITs: How Do They Compare?
|
|
Dec 29
|
Is Summit Hotel Properties (INN) Stock Undervalued Right Now?
|
|
Nov 3
|
Innocan Pharma Announces Promising LPT-CBD Safety Indications -Implications from a prolong use in animals
|